Postmenopausal hormone therapy: an Endocrine Society scientific statement

RJ Santen, DC Allred, SP Ardoin… - The Journal of …, 2010 - academic.oup.com
Objective: Our objective was to provide a scholarly review of the published literature on
menopausal hormonal therapy (MHT), make scientifically valid assessments of the available …

Current and emerging pharmacological targets and treatments of urinary incontinence and related disorders

MC Michel, L Cardozo, CJ Chermansky, F Cruz… - Pharmacological …, 2023 - ASPET
Overactive bladder syndrome with and without urinary incontinence and related conditions,
signs, and disorders such as detrusor overactivity, neurogenic lower urinary tract …

Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis

W Everaerts, X Zhen, D Ghosh… - Proceedings of the …, 2010 - National Acad Sciences
Reduced functional bladder capacity and concomitant increased micturition frequency
(pollakisuria) are common lower urinary tract symptoms associated with conditions such as …

EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part I diagnostics and conservative treatment

R Stein, G Bogaert, HS Dogan, L Hoen… - Neurourology and …, 2020 - Wiley Online Library
Background In childhood, the most common reason for a neurogenic bladder is related to
spinal dysraphism, mostly myelodysplasia. Aims Herein, we present the EAU/ESPU …

Antimuscarinic mechanisms and the overactive detrusor: an update

KE Andersson - European urology, 2011 - Elsevier
CONTEXT: Antimuscarinics are the drugs of choice for the treatment of detrusor overactivity
(DO) and overactive bladder (OAB) syndrome. However, the mechanisms for their beneficial …

Systematic review and meta‐analysis on the efficacy and tolerability of mirabegron for the treatment of storage lower urinary tract symptoms/overactive bladder …

A Sebastianelli, GI Russo, SA Kaplan… - … Journal of Urology, 2018 - Wiley Online Library
A systematic review and meta‐analysis was carried out to evaluate the efficacy and safety of
mirabegron 50 mg and 100 mg in the treatment of storage lower urinary tract …

Treatment of advanced Parkinson′ s disease

S Varanese, Z Birnbaum, R Rossi… - Parkinson's …, 2010 - Wiley Online Library
Patients at late stage Parkinson′ s disease (PD) develop several motor and nonmotor
complications, which dramatically impair their quality of life. These complications include …

International Children's Continence Society's recommendations for initial diagnostic evaluation and follow‐up in congenital neuropathic bladder and bowel …

SB Bauer, PF Austin, YF Rawashdeh… - Neurourology and …, 2012 - Wiley Online Library
Purpose The objective of this ICCS standardization document is to report the initial
diagnostic evaluation and subsequent work‐up of children with neuropathic bladder …

Flexible‐dose fesoterodine in elderly adults with overactive bladder: results of the randomized, double‐blind, placebo‐controlled study of fesoterodine in an aging …

A Wagg, V Khullar, D Marschall‐Kehrel… - Journal of the …, 2013 - Wiley Online Library
Objectives To assess the efficacy and safety of flexible‐dose fesoterodine in elderly adults
with overactive bladder (OAB). Design Twelve‐week, randomized, double‐blind, placebo …

A multicenter, double-blind, randomized, placebo-controlled trial of the β3-adrenoceptor agonist solabegron for overactive bladder

EH Ohlstein, A Von Keitz, MC Michel - European urology, 2012 - Elsevier
BACKGROUND: β-Adrenoceptor agonists are effective in animal models of bladder
dysfunction, and the human bladder primarily expresses the β3 receptor subtype …